All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential effective ...

Researchers have mapped the genetic landscape of cancer drug resistance, uncovering that DNA changes can be grouped into four ...

Cambridge scientists and collaborators have mapped drug resistance across different cancers, highlighted DNA changes that may ...

All women should start mammograms at age 40 to screen for breast cancer, regardless of family history. Sponsored by Virginia Mason Franciscan Health.

BioAffinity Technologies shares declined after the company announced a $2.66 million registered direct offering of stock and a concurrent private placement of warrants. Shares were down 25%, to $1.59, ...

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, provided an update today on the company's efforts to secure supplies of critical IV fluids in response to ...

WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that? bioAffinity Technologies, Inc. , a biotechnology company focused on the need ...

A ChatGPT-like model can diagnose cancer, assist in selecting treatment options, and predict survival outcomes across various ...

Researchers obtain detailed picture of the specific mechanisms by which each individual mutation studied impacts drug response.

Is AI just hype or a game-changer? Delve into AI's contribution to oncology, from diagnostics to drug discovery and ...